Comparative effectiveness of "liberal" and "restrictive" modes of intraoperative infusion-transfusion therapy in lung transplantation

Introduction. Recently, researchers have paid considerable attention to the strategy of intraoperative infusiontransfusion therapy in traumatic surgical interventions. The choice of a “restrictive” regimen during surgery in many studies has reduced the incidence and severity of intra- and postoperative complications.
Objective. Comparison of the effectiveness of "liberal" and "restrictive" intraoperative infusion-transfusion therapy in lung transplantation.
Material and methods. The study included 58 patients who underwent bilateral lung transplantation at N.V. Sklifosovsky Research Institute for Emergency Medicine in the period 2012-2019. The patients were divided into 2 groups: the comparison group included 31 patients, the total volume of intraoperative infusion-transfusion in whom was 14386.9 ± 1310.0 ml (16.5 ml/kg/h). Group II consisted of 27 patients; their total volume of intraoperative infusion-transfusion during surgery was 10251.3 ± 740.1 ml (12.9 ml/kg/hour). The analysis we performed included the volume and composition of intraoperative infusion-transfusion therapy, the volume of blood loss, clinical and laboratory data, the duration of mechanical ventilation, the frequency of intraoperative use of veno-arterial extracorporeal membrane oxygenation and the duration of its use after surgery, mortality.
Results. When using the "restrictive" fluid therapy for lung transplantation, we observed a decrease in the volume of intraoperative blood loss by 1.3 times, the volume of transfusion of blood components, including fresh frozen plasma by 37%, erythrocyte suspension by 3.1 times, and instrumental reinfusion of autoerythrocytes by 1.56 times. At the same time, we revealed a decrease by 2.7 times in the duration of the mechanical ventilation use, a decreased frequency of using veno-arterial extracorporeal membrane oxygenation during surgery by 1.3 times, and a decreased duration of using veno-arterial extracorporeal membrane oxygenation after surgery by 2.3 times. Mortality was 38.7% in group I, and 30.7% in group II.
Conclusion. The “restrictive” approach to intraoperative infusion-transfusion therapy in lung transplantation seems a promising new trend requiring further study and gaining the experience.

1. Tomasi R, Betz D, Schlager S, Kammerer T, Hoechter DJ, Weig T, et al. Intraoperative anesthetic management of lung transplantation: centerspecific practices and geographic and centers size differences. J Cardiothorac Vasc Anesth. 2018;32(1):62–69. PMID: 29174123 https://doi.org/10.1053/j.jvca.2017.05.025

2. Kurilova OА, Zhuravel SV, Romanov AA, Marinin PN, Tsurova DKh, Kallagov TE, et al. Experience with application of extracorporeal membrane oxygenation in double lung transplantation. Russian Journal of Transplantology and Artificial Organs. 2014;16(2):66–74. (In Russ.). https://doi.org/10.15825/1995-1191-2014-2-66-74

3. Miranda A, Zink R, McSweeney M. Anesthesia for Lung Transplantation. Semin Cardiothorac Vasc Anesth. 2005;9(3):205–212. PMID: 16151553 https://doi.org/10.1177/108925320500900303

4. Della Rocca G, Brondani A, Costa MG. Intraoperative hemodynamic monitoring during organ transplantation: what is new? Curr Opin Organ Transplant. 2009;14(3):291–296. PMID: 19448537 https://doi.org/10.1097/mot.0b013e32832d927d

5. Weiss ES, Allen JG, Meguid RA, Patel ND, Merlo CA, Orens JB, et al. The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg. 2009;88(4):1062–1070. PMID: 19766782 https://doi.org/10.1016/j.athoracsur.2009.06.005

6. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction: part II definition. J Heart Lung Transplant. 2005;24(10):1454– 1459. PMID: 16210116 https://doi.org/10.1016/j.healun.2004.11.049

7. Prekker ME, Nath DS, Walker AR, Johnson AC, Hertz MI, Herrington CS, et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2006;25(4):371–378. PMID: 16563963 https://doi.org/10.1016/j.healun.2005.11.436

8. Kravets OV, Klygunenko OM. Оptimal strategy of perioperative infusion: pros and cons. Emergency Medicine = Medicina neotložnyh sostoânij. 2019;(3):14–20. (In Russ.). https://doi.org/10.22141/2224-0586.3.98.2019.165472

9. Zabolotskikh IB, Protsenko DN. (ed.) Intensivnaya terapiya: natsional'noe rukovodstvo: in 2 vol. V. 1. 2nd ed., revised and enlarged. Moscow: GEOTAR-Media Publ.; 2020. (In Russ.).

10. Giorgio D. Rocca, Luigi V, Gabriella T, Cristian D, Federico B, Livia P. Liberal or restricted fluid administration: are we ready for a proposal of a restricted intraoperative approach? BMC Anesthesiol. 2014;14:62. PMID: 25104915 https://doi/org/10.1186/1471-2253-14-62eCollection 2014.

11. Mythen MG, Swart M, Acheson N, Crawford R, Jones K, Kuper M, et al. Perioperative fluid management: consensus statement from the enhanced recovery partnership. Perioper Med (Lond). 2012;1:2. PMID: 24764518 https://doi.org/10.1186/2047-0525-1-2

12. Watt DG, McSorley ST, Horgan PG, McMillan DC. Enhanced recovery after surgery: which components, if any, impact on the systemic inflammatory response following colorectal surgery? A systematic review. Medicine (Baltimore). 2015;94(36):e1286. PMID: 26356689 https://doi.org/10.1097/MD.0000000000001286

13. Minto G, Mythen MG. Perioperative fluid management: science, art or random chaos? Br J Anaesth. 2015;114(5):717–721. PMID: 25794505 https://doi.org/10.1093/bja/aev067

14. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens:a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238(5):641–648. PMID: 14578723 https://doi.org/10.1097/01.sla.0000094387.50865.23

15. Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology. 2005;103(1):25–32. PMID: 15983453 https://doi.org/10.1097/00000542-200507000-00008

16. Dzyadzko AM, Katin ML, Chugunova OA, Minov AF, Oganova EG, Santotskiy EO, et al. The effect of using the algorithm of restrictive intraoperative fluid therapy, early immune enteral nutrition, and early patient mobilization on orthotopic liver transplantation outcomes. Transplantologiya. The Russian Journal of Transplantation. 2016;(3):10–20. (In Russ.).

17. Tipisev DA, Gorobets ES, Gruzdev VE, Anisimov MA, Borovkova NB, Kochkovaya EO. Whether postoperative mechanical ventilation is always mandatory for patients suffered of intraoperative massive hemorrhage in elective surgery: arguments and cases of single hospital. Intensive Care Herald. 2016;4:52–58. (In Russ.).

18. Mierzweska-Schmidt M. Intraoperative fluid management in children – a comparison of three fluid regimes. Anaesthesiol Intensive Ther. 2015;47(2):125– 130. PMID: 25940329 https://doi.org/10.5603/AIT.2015.0012

19. McIlroy DR, Pilcher DV, Snell GI. Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis. Br J Anaesth. 2009;102(4):506–514. PMID: 19224927 https://doi.org/10.1093/bja/aep008

20. Geube MA, Perez-Protto SE, McGrath TL, Yang D, Sessler DI, Budev MM, et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation. Anesth Analg. 2016;122(4):1081–1088. PMID: 26991618 https://doi.org/10.1213/ANE.0000000000001163

21. Castillo M. Anesthetic management for lung transplantation. Curr Opin Anaesthesiol. 2011;24(1):32–36. PMID: 21084981 https://doi.org/10.1097/aco.0b013e328341881b

22. Lee JC, Christie JD, Keshavjee S. Primary graft dysfunction: definition, risk factors, short- and long-term outcomes. Semin Respir Crit Care Med. 2010;31(2):161–171. PMID: 20354929 https://doi.org/10.1055/s-0030-1249111

23. Sugita M, Ferraro P, Dagenais A, Clermont ME, Barbry P, Michel RP, et al. Alveolar liquid clearance and sodium channel expression are decreased in transplanted canine lungs. Am J Respir Crit Care Med. 2003;167(10):1440–1450. PMID: 12738601 https://doi.org/10.1164/rccm.200204-312OC

24. Peltracco P, Falasco G, Barbieri S, Milevoj M, Serra E, Ori C. Anesthetic considerations for nontransplant procedures in lung transplant patients. J Clin Anesth. 2011;23(6):508–516. PMID: 21911200 https://doi.org/10.1016/j.jclinane.2011.05.002

25. Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, Keshavjee S. Report of the ISHLT working group on primary lung graft dysfunction part VI: treatment. J Heart Lung Transplant. 2005;24(10):1489–1500. PMID: 16210120 https://doi.org/10.1016/j.healun.2005.03.011

26. Arif SK, Verheij J, Groeneveld AB, Raijmakers PG. Hypoproteinemia as a marker of acute respiratory distress syndrome in critically ill patients with pulmonary edema. Intensive Care Med. 2002;28(3):310–317. PMID: 11904661 https://doi.org/10.1007/s00134-002-1220-y

27. Groeneveld AB. Radionuclide assessment of pulmonary microvascular permeability. Eur J Nucl Med. 1997;24(4):449–461. PMID: 9096099 https://doi.org/10.1007/BF00881821

28. Sankar NM, Ramani SS, Vaidyanathan K, Cherian KM. Anaesthetic and perioperative management of lung transplantation. Indian J Anaesth. 2017;61(2):173–175. PMID: 28250489 https://doi.org/10.4103/ija.IJA_512_16

29. Navarro LH, Bloomstone JA, Auler JO Jr, Cannesson M, Rocca GD, Gan TJ, et al. Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioper Med (Lond). 2015;4:3. PMID: 25897397 https://doi.org/10.1186/s13741-015-0014-zeCollection2015.

30. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013;187(5):527–534. PMID: 23306540 https://doi.org/10.1164/rccm.201210-1865OC

31. Liu Y, Liu Y, Su L, Jiang SJ. Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis. PLoS One. 2014;9(3):e92773. PMID: 24658073 https://doi.org/10.1371/journal. pone.0092773 eCollection 2014.

32. DeLima NF, Binns OA, Buchanan SA, Mauney MC, Cope JT, Shockey KS, et al. Euro-Collins solution exacerbates lung injury in the setting of highflow reperfusion. J Thorac Cardiovasc Surg. 1996;112(1):111–116. PMID: 8691854 https://doi.org/10.1016/s0022-5223(96)70184-8

33. Oechslin P, Zalunardo MP, Inci I, Schlaepfer M, Grande B. Established and potential predictors of blood loss during lung transplant surgery. J Thorac Dis. 2018;10(6):3845–3848. PMID: 30069385 https://doi.org/10.21037/jtd.2018.05.165

34. Lodewyks C, Heinrichs J, Grocott HP, Karkouti K, Romund G, Arora RC, et al. Point-of-care viscoelastic hemostatic testing in cardiac surgery patients: A systematic review and meta-analysis. Can J Anaesth. 2018;65(12):1333–1347. PMID: 30194674 https://doi.org/10.1007/s12630-018-1217-9

35. Smith I, Pearse BL, Faulke DJ, Naidoo R, Nicotra L, Hopkins P, et al. Targeted bleeding management reduces the requirements for blood component therapy in lung transplant recipients. J Cardiothorac Vasc Anesth. 2017;31(2):426– 433. PMID: 27692703 https://doi.org/10.1053/j.jvca.2016.06.027

36. Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications. Transfusion. 2013;53(4):798–804. PMID: 22845023 https://doi.org/10.1111/j.1537-2995.2012.03801.x

37. Barac YD, Klapper J, Pollack A, Poisson J, Welsby I, Hartwig MG, et al. Anticoagulation strategies in the perioperative period for lung transplant. Ann Thorac Surg. 2020;110(1):e23–e25. PMID: 31981503 https://doi.org/10.1016/j.athoracsur.2019.11.056

38. Rhodes A, Cecconi M, Hamilton M, Poloniecki J, Woods J, Boyd O, et al. Goal-directed therapy in high-risk surgical patients: A 15-year follow-up study. Intensive Care Med. 2010;36(8):1327– 1332. PMID: 20376431 https://doi.org/10.1007/s00134-010-1869-6

39. Pestaña D, Espinosa E, Eden A, Nájera D, Collar L, Aldecoa C, et al. Perioperative goal-directed hemodynamic optimization using noninvasive cardiac output monitoring in major abdominal surgery: A prospective, randomized, multicenter, pragmatic trial: POEMAS Study (PeriOperative goal-directed thErapy in Major Abdominal Surgery). Anesth Analg. 2014;119(3):579–587. PMID: 25010820 https://doi.org/10.1213/ANE.0000000000000295

40. Martin AK, Yalamuri SM, Wilkey BJ, Kolarczyk L, Fritz AV, Jayaraman A, et al. The Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation. J Cardiothorac Vasc Anesth. 2020;34(6):1669–1680. PMID: 31623969 https://doi.org/10.1053/j.jvca.2019.08.037